HRAS and cancer: n = 70 metastatic or unresectable cancers with G12D mutated KRAS, NRAS or HRAS, HLA-A*11:01 positive, no prior therapy or nonresponders; PDAC, GI cancer, gastric cancer, colon cancer, rectal cancer